US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

  • Biopharmaceuticals (204)
  • Diseases & Conditions (4228)
  • Drug Delivery (179)
  • Therapeutic Area (6531)
  • Vaccines (612)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Cancer Therapeutics
10/5/2015 | published by: Kalorama Information
Kalorama's Cancer Therapeutics provides market estimates and forecasts for the market for cancer treatments.  This title will focus on novel treatments.    |  read more...
USD 3,995
The US Market for Rx to OTC Switches, 7th Edition
2/2/2015 | published by: Kalorama Information
... expirations, increasing competitiveness with the pharmaceutical environment, brand re-invention, consumer demand, and cost containment strategies. The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as ...  |  read more...
USD 3,995
Global Glycated Hemoglobin Testing Market 2015-2019
2/25/2015 | published by: TechNavio - Infiniti Research Ltd.
... to determine a person's average blood glucose level over a period. It is a standardized test recommended by doctors for the diagnosis of type 2 diabetes or to test the control level of the blood ...  |  read more...
USD 2,500
Global Sexual Wellness Market 2015-2019
2/25/2015 | published by: TechNavio - Infiniti Research Ltd.
... contraceptives, costumes, accessories, adult games, oils, and herbal supplements. These products are used for sexual wellbeing, to enhance pleasure, and to induce an element of adventure during intimacy. TechNavio's analysts forecast the Global Sexual Wellness ...  |  read more...
USD 3,000
Canada Pharmaceuticals and Healthcare Report Q2 2015
2/25/2015 | published by: Business Monitor International
... one of the largest inworld. We believe that drugmakers will continue to realise considerable rewards, as sales of patentedpharmaceuticals settle into a trend of steady growth, which is only nominally affected by the particularlyslow penetration ...  |  read more...
USD 1,295
France Pharmaceuticals and Healthcare Report Q2 2015
2/25/2015 | published by: Business Monitor International
... capita spending levels on medicines. However, several cost-containment measures will continue to exert downward pressure on market growthover a multi-year horizon. On the upside, current macroeconomic trends, including low oil and food prices,should be net ...  |  read more...
USD 1,295
Myanmar Pharmaceuticals and Healthcare Report Q2 2015
2/25/2015 | published by: Business Monitor International
... the opportunity ofsecuring a first-mover advantage in this frontier market, as well as being a result of rising medicineconsumption. Nonetheless, we highlight that there is significant political uncertainty in Myanmar with theupcoming 2015 elections which ...  |  read more...
USD 1,295
Colombia Pharmaceuticals and Healthcare Report Q2 2015
2/11/2015 | published by: Business Monitor International
... and expanding counterfeit drug market continue to hinder progress for the Colombian governmentand pharmaceutical market. Headline Expenditure Projections Pharmaceuticals: COP8,643bn (USD4.38bn) in 2014 to COP9,118bn (USD4.3bn) in 2015; +5.5% inlocal currency terms and -2.1% in ...  |  read more...
USD 1,295
Cameroon Pharmaceuticals and Healthcare Report Q2 2015
2/11/2015 | published by: Business Monitor International
... combination of rising consumer spending, global aid funds and Cameroon's government recentcommitment to enhance investment through 2015-2018 in several key areas, including the health sector,will sustain market development. Meanwhile, we expect mobile health innovations to ...  |  read more...
USD 1,295
Global Transdermal Drug Delivery Market To 2020 Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment And Swot Investigation
2/13/2015 | published by: Kelly Scientific Publications
... influential technologies, and business and economic environments. The report is supported by 320 tables & figures over 280 pages. This report is presented as follows: By Company (e.g., JANSSEN, MYLAN, ACTAVIS, GLAXOSMITHKLINE, BAYER, NOVARTIS, NOVEN, ...  |  read more...
USD 3,400
Competitor Analysis: Her2 Antibodies 2015 - Biosimilars and Biosuperiors of Herceptin
2/15/2015 | published by: La Merie Publishing
... antibodies targeting Her2 for treatment of Her2 positive breast and gastric cancer as of February 2015. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ...  |  read more...
USD 390
New Zealand Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: Business Monitor International
... ageing andexpanding population. However, the conversion of such potential into rewards for multinationals willremain largely dependent upon PHARMAC's budget which, already oversubscribed, is unlikely to receivesignificant extensions to its annual increase over our forecast period. ...  |  read more...
USD 1,295
Argentina Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: Business Monitor International
... in the long-term, including the pharmaceutical industry. We sustain our view thatundervalued local drugmakers could be acquisition targets for foreign firms willing to enhance theirfootprint in the region as the economy stabilizes. On the upside, ...  |  read more...
USD 1,295
Bulgaria Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: Business Monitor International
... healthcare financing, we holda more positive view for the long term development of the pharmaceutical & healthcare sector. Headline Expenditure Projections Pharmaceuticals: BGN2.50bn (USD1.71bn) in 2014 to BGN2.41bn (USD1.54bn) in 2015; -3.7% inlocal currency terms ...  |  read more...
USD 1,295
Germany Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: Business Monitor International
... patented medicines. In spiteof this, additional restrictions on reimbursement, tempered by government's desire to preserve an industryintegral to Germany's positive balance of trade and international prestige, will nonetheless constrainrevenues and intensify already fierce competition amongst ...  |  read more...
USD 1,295
Jordan Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: Business Monitor International
... toSyrian refugees in Jordan. The government will have more funds to invest in the development of the publichealthcare sector, which was previously overburdened with refugees, though regional instability willcontinue to weigh on Jordan's attractiveness as ...  |  read more...
USD 1,295
Mozambique Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: Business Monitor International
... healthcare sector - which suffers from shortages of health professionals andpoor access to treatment facilities - should begin to show signs of improvement with the help of foreigninvestment. However, previous risks to market growth remain ...  |  read more...
USD 1,295
Poland Pharmaceuticals and Healthcare Report Q2 2015
2/18/2015 | published by: Business Monitor International
... Over the past fiveyears, Poland's economic outperformance has been vital to maintaining positive growth for the private andpublic healthcare sectors. While Poland's economy may continue to outperform in terms of growth, webelieve that overall healthcare ...  |  read more...
USD 1,295
Cystic Fibrosis Market in Europe 2015-2019
2/18/2015 | published by: TechNavio - Infiniti Research Ltd.
... difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic fibrosis is one of the most common genetic disorders observed in Caucasian children. Rare diseases are those that affect ...  |  read more...
USD 3,000
Global Infertility Market 2015-2019
2/18/2015 | published by: TechNavio - Infiniti Research Ltd.
... infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors ...  |  read more...
USD 2,500
Hematological Malignancies: Multiple Myeloma (MM) – Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease
2/24/2015 | published by: MP Advisors
... cancer through innovative drug development strategies have witnessed favorable outcomes, the specific choice of the therapies is dependent on the identification of important genomic alterations in cancerous cells that allow for the tumor’s sub classification. ...  |  read more...
USD 3,000
Global Packaging Film Market 2015-2019
2/18/2015 | published by: TechNavio - Infiniti Research Ltd.
... relatively cheap, and can be molded into a variety of shapes and dimensions, making it a material of choice for packaging. Its inert nature and ability to preserve products for a long period of time ...  |  read more...
USD 3,000
New Phase of Mab biosimilar knocks the door Biosimilar Oppurtunities In Japan
2/22/2015 | published by: MP Advisors
... in adapting to biosimilar use. After nine years of continuous efforts by the JP government to promote increased use of generics (started in 2006 by launching various benefits for GE use at Pharmacy, hospital level) ...  |  read more...
USD 4,000
Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 446000
2/19/2015 | published by: Plunkett Research, Ltd.
... growth rates and forecasts that will save countless hours of research. Key Findings: Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores Industry (U.S.) to reach $407.8 billion by 2021. Drug Stores ...  |  read more...
USD 1,995
Pharmacies and Drug Stores Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 446110
2/19/2015 | published by: Plunkett Research, Ltd.
... hours of research. Key Findings: Pharmacies and Drug Stores Industry (U.S.) to reach $340 billion by 2021. Pharmacies and Drug Stores Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: ...  |  read more...
USD 1,995
< prev 1    3  4  5  6  7  8  9  10